Deletion of the steroid 21-hydroxylase and complement C4 genes in congenital adrenal hyperplasia

Insights

Genetic analysis of 20 congenital adrenal hyperplasia patients revealed a homozygous deletion of the C4B and 21-hydroxylase B genes in one individual. This deletion likely resulted from recombination between 21-hydroxylase A and B gene regions.

Area of Science:

  • Genetics
  • Molecular Biology
  • Endocrinology

Background:

  • Congenital adrenal hyperplasia (CAH) is a group of genetic disorders affecting adrenal steroid production.
  • Cytochrome P-450 steroid 21-hydroxylase deficiency is the most common cause of CAH.
  • The 21-hydroxylase gene and the fourth component of complement (C4) gene are located in close proximity on chromosome 6p21.3.

Purpose of the Study:

  • To investigate the genetic basis of 21-hydroxylase deficiency in patients with CAH.
  • To identify potential DNA deletions or rearrangements involving the 21-hydroxylase gene and the adjacent C4 gene.

Main Methods:

  • DNA analysis was performed on 20 patients diagnosed with CAH.
  • Probes specific to the 21-hydroxylase gene and the C4 gene were utilized.
  • Southern blot hybridization was employed to detect DNA deletions and rearrangements.

Main Results:

  • One patient presented with a homozygous deletion encompassing both the C4B and 21-hydroxylase B genes.
  • Evidence suggests this deletion arose from unequal crossing-over between homologous regions of the 21-hydroxylase A and B genes.
  • Seven additional patients were found to be heterozygous for the same deletion.

Conclusions:

  • The study identified a specific DNA deletion associated with 21-hydroxylase deficiency in CAH patients.
  • Recombination between homologous 21-hydroxylase gene regions is a plausible mechanism for generating such deletions.
  • Further investigation is warranted to understand the clinical implications of heterozygous deletions.

Related Concept Videos

Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
X-Inactivation01:58

X-Inactivation

The human X chromosome contains over ten times the number of genes as in the Y chromosome. Since males have only one X chromosome, and females have two, one might expect females to produce twice as many of the proteins, with undesirable results.
Exon Recombination02:32

Exon Recombination

The evolution of new genes is critical for speciation. Exon recombination, also known as exon shuffling or domain shuffling, is an important means of new gene formation. It is observed across vertebrates, invertebrates, and in some plants such as potatoes and sunflowers. During exon recombination, exons from the same or different genes recombine and produce new exon-intron combinations, which might evolve into new genes. 
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cushing Syndrome I: Introduction01:26

Cushing Syndrome I: Introduction

Cushing syndrome refers to the collection of clinical manifestations that arise when tissues are exposed to excessive amounts of cortisol or cortisol-like medications over an extended period. Cortisol, a glucocorticoid produced by the adrenal cortex, regulates metabolism, immune responses, and the body’s adaptation to stress. When its concentration remains chronically elevated, these physiological pathways become dysregulated, resulting in the characteristic features of the syndrome.Exogenous...
Cushing Syndrome II: Pathophysiology01:19

Cushing Syndrome II: Pathophysiology

Cortisol production is normally governed by the hypothalamic–pituitary–adrenal (HPA) axis, which maintains hormonal balance through tightly regulated feedback mechanisms. Disruption of this regulatory system is central to the development of Cushing syndrome, whether the excess cortisol originates from external medications or internal pathology. Persistent cortisol elevation alters metabolism, immune function, and endocrine signaling, producing the characteristic clinical features of the...